P10, Inc. sees $4.58 million in stock sales by large investors Via Investing.com
DALLAS—Major shareholders of P10, Inc. (NYSE:PX) recently sold a large amount of the company’s stock, according to a recent filing with the Securities and Exchange Commission. The transaction was led by a group of investors, including 210 Capital, LLC, Covenant RHA Partners, LP, and CCW/LAW Holdings, LLC, among others.
On November 6 and November 8, these investors sold a combined total of 392,187 shares of P10, Inc.’s Class A Common Stock, netting approximately $4.58 million. Shares traded at prices ranging from $11.54 to $11.69 per share. This sale was made under a pre-arranged trading plan, approved by 210/P10 on December 10, 2023.
Following this transaction, the reporting entities continue to hold significant positions in the company. As of the latest filing, 210 Capital, LLC and its affiliates maintain ownership of more than 2 million shares.
The sale was part of routine portfolio management and was conducted under the trading plans of Rule 10b5-1, which allows company insiders to set up a predetermined plan to sell stock. This strategy helps avoid concerns about insider trading.
In other recent news, P10 Inc (NYSE: has announced a series of important events. The company reported a 14% increase in Q2 2024 revenue, to $71 million, and significant growth in cash-paying assets under management. Despite a 3% decline in Revenue, P10 Inc. raised and issued $844 million in gross new assets, reflecting a strategic focus on expansion. In addition, P10 Inc. has expanded its European presence with the acquisition of Madrid-based Qualitas Equity Funds SGEIC, SA for an initial consideration of $63 million.
The company also announced the resignation of two board members, Robert Alpert and C. Clark Webb, in a peaceful departure not related to any disagreement about operations, policies, or procedures. In terms of analyst ratings, P10 Inc. received mixed reviews. Stephens maintained an Overweight rating on the company, citing its unique market position and strong financial profile. In contrast, UBS downgraded P10 stock from Buy to Neutral, citing concerns about the potential for imminent acquisitions and valuations.
This latest development shows the growth of P10 Inc.’s strategy. and potential concerns about near-term benefits. Please note, this article does not contain personal opinion, predictions, or conclusions, and only reports the latest developments regarding P10 Inc.
InvestingPro Insights
Although key shareholders have recently sold P10, Inc. stock. (NYSE:PX), the company’s financial metrics and market performance paint an interesting picture. According to InvestingPro data, P10 has a market capitalization of $1.27 billion and is trading near its 52-week high, with the current price at 98.23% of that peak. This strong performance is underlined by a strong price return of 26.03% in the last three months.
InvestingPro Tips highlights that P10 trades at a low P/E ratio relative to its near-term earnings growth, suggesting potential value for investors despite recent internal sales. A company’s liquid assets exceeding short-term obligations indicate a strong financial position, which may provide reassurance to shareholders due to recent stock losses.
It is worth noting that the P10 has shown a profit for the past twelve months, with analysts predicting continued profits this year. This positive outlook is coupled with the company’s revenue growth of 15.82% over the past twelve months and a significant quarterly revenue growth of 25.96% from Q3 2024.
For investors looking for a comprehensive analysis, InvestingPro offers additional tips and insights that can shed more light on P10’s financial position and growth prospects. Currently, there are 5 other InvestingPro Tips available for P10, which can provide valuable context on the company’s latest internal sales activity and overall market situation.
This article was created with the support of AI and reviewed by an editor. For more information see our T&C.
